FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients with a history of severe tachyarrhythmia Patients treated concomitantly with two or more additional antiplatelet or anticoagulant agents (e.g. acetylsalicylic acid, clopidogrel, heparin, warfarin, acenocoumarol, dabigatran, rivaroxaban or apixaban)
Slovenian: • bolniki, ki se sočasno zdravijo z dvema ali več dodatnimi protitrombocitnimi ali antikoagulantnimi zdravili (npr. acetilsalicilna kislina, klopidogrel, heparin, varfarin,
English: Acetylsalicylic Acid (ASA)
Slovenian: Acetilsalicilna kislina (ASK)
English: Based on these data, the recommended dose of cilostazol is 50 mg bid in the presence of erythromycin and similar agents (e.g., clarithromycin).
Slovenian: Na podlagi teh podatkov je priporočeni odmerek cilostazola 50 mg dvakrat na dan v prisotnosti eritromicina in podobnih učinkovin (npr. klaritromicina).
English: • anticoagulant medicines (e.g. warfarin, dabigatran, rivaroxaban, apixaban or low molecular weight heparins).
Slovenian: • antikoagulante (npr. varfarin, dabigatran, rivaroksaban, apiksaban ali nizkomolekularne heparine).
English: Before you start taking <Cilostazol-containing medicinal product>, please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Slovenian: Druga zdravila in <zdravilo, ki vsebuje cilostazol> Obvestite svojega zdravnika ali farmacevta, če uporabljate, ste pred kratkim uporabljali ali pa boste morda začeli uporabljati katero koli drugo zdravilo.
English: They may either increase the side effects of <Cilostazol-containing medicinal product> or make <Cilostazol-containing medicinal product> less effective.
Slovenian: Neželene učinke <zdravila, ki vsebuje cilostazol>, lahko povečajo, ali zmanjšajo učinkovitost zdravila, ki vsebuje cilostazol.
English: The frequencies correspond with: Very common (≥1/10) Common (≥1/100 to <1/10) Uncommon (≥1/1,000 to <1/100) Rare
Slovenian: zelo pogosti (≥1/10) pogosti
English: The dehydro metabolite, which has 4-7 times the potency of cilostazol in inhibiting platelet aggregation, appears to be formed primarily via CYP3A4.
Slovenian: Kaže, da nastaja presnovek dehidro, ki ima 4-7-kratno jakost cilostazola pri zaviranju agregacije trombocitov, pretežno s CYP3A4.
English: Cilostazol should be discontinued promptly if there is clinical or laboratory evidence of haematological abnormalities.
Slovenian: Pri kliničnih ali laboratorijskih dokazih hematoloških nepravilnosti je treba z uporabo cilostazola takoj prenehati.
English: Congestive heart failure
Slovenian: • kongestivno srčno popuščanje
English: Cilostazol did not alter fertility in animal studies.
Slovenian: V študijah pri živalih cilostazol ni vplival na plodnost.
English: Cilostazol is contraindicated in patients with a creatinine clearance of  25 ml/min.
Slovenian: Cilostazol je kontraindiciran pri bolnikih z očistkom kreatinina  25 ml/min.
English: Uric acid level increased, blood urea increased, blood creatinine increased
Slovenian: Preiskave neznana zvišanje ravni sečne kisline, zvišanje sečnine v krvi, zvišanje kreatinina v krvi
English: • ACE inhibitors (e.g., captopril, lisinopril)
Slovenian: • zaviralce ACE (npr. kaptopril, lizinopril)
English: The 4`-trans-hydroxy metabolite, with potency one-fifth that of cilostazol, appears to be formed primarily via CYP2C19.
Slovenian: Kaže, da nastaja presnovek 4`-trans-hidroksi, ki ima eno petino jakosti cilostazola, pretežno s CYP2C19.
English: Certain medicines may interfere with the effect of <Cilostazol-containing medicinal product> when taken together.
Slovenian: Nekatera zdravila lahko ob sočasni uporabi vplivajo na učinek <zdravila, ki vsebuje cilostazol>.
English: Cilostazol per se may carry an increased risk of bleeding and this risk may be potentiated by coadministration with any other agent with such potential.
Slovenian: Cilostazol sam po sebi lahko pomeni večje tveganje za krvavitev, to tveganje pa lahko sočasna uporaba drugih zdravil z enakim učinkom še poveča.
English: There may be a higher risk of bleeding into the eye in people with diabetes.
Slovenian: Pri bolnikih s sladkorno boleznijo je lahko tveganje krvavitve v oko povečano.
English: The stomach should be emptied by induced vomiting or gastric lavage, as appropriate.
Slovenian: Po potrebi jim je treba izprazniti želodec z izzvanim bruhanjem ali izpiranjem želodca.
English: The following side effects have been reported during the use of <Cilostazol-containing medicinal product> but it is not known how frequently they may occur:
Slovenian: Med uporabo <zdravila, ki vsebuje cilostazol>, so poročali o naslednjih neželenih učinkih z neznano pogostnostjo:
English: Pregnancy and breast-feeding <Cilostazol-containing medicinal product> MUST NOT be used during pregnancy.
Slovenian: <Zdravila, ki vsebuje cilostazol>, NE SMETE jemati med nosečnostjo.
English: Eczema, skin eruptions, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria
Slovenian: Bolezni kože in podkožja pogosti izpuščaj, pruritus neznana ekcem, kožni izpuščaji, Stevens-Johnsonov sindrom, toksična epidermalna nekroliza, urtikarija
English: stroke heart attack heart problems which can cause shortness of breath or ankle swelling irregular heart beat (new or worsening)
Slovenian: • težave s srcem, ki lahko povzročijo zasoplost ali oteklost gležnjev
English: White, round, flat faced tablets debossed with “OG30” on one side.
Slovenian: bele, okrogle, ploske tablete z natisom "OG30" na eni strani.
English: The pharmacokinetics of cilostazol and its metabolites were not significantly affected by age or gender in healthy subjects aged between 50-80 years.
Slovenian: Pri zdravih osebah, starih med 50-80, starost ali spol nimata bistvenega vpliva na farmakokinetiko cilostazola in njegovih presnovkov.
English: Based on these data, the recommended dose of cilostazol is 50 mg bid in the presence of omeprazole.
Slovenian: Na podlagi teh podatkov je priporočeni odmerek cilostazola 50 mg dvakrat na dan v prisotnosti omeprazola.
English: produced a reduction in triglycerides of 0.33 mmol/l (15%) and an increase in HDL-cholesterol of 0.10 mmol/l (10%).
Slovenian: Po 12 tednih je v primerjavi s placebom <zdravilo, ki vsebuje cilostazol>, 100 mg dvakrat na dan, povzročilo zmanjšanje trigliceridov za 0,33 mmol/l (15 %) in povečanje HDL-holesterola za 0,10 mmol/l (10 %).
English: HOW TO TAKE <CILOSTAZOL-CONTAINING MEDICINAL PRODUCT>
Slovenian: Kako jemati <zdravilo, ki vsebuje cilostazol>
English: No dose adjustment is necessary in patients with a creatinine clearance of > 25 ml/min.
Slovenian: Odmerka pri bolnikih z očistkom kreatinina > 25 ml/min ni treba prilagoditi.
English: The <Cilostazol-containing medicinal product> 100 mg tablet is a white, round, flat-faced tablet, debossed with “OG30” on one side.
Slovenian: <Zdravilo, ki vsebuje cilostazol>, 100 mg tablete, so bele, okrogle, ploske tablete z vtisom "OG30" na eni strani.
English: Very common side effects (affecting more than 1 in 10 people) headache abnormal stools diarrhoea
Slovenian: zelo pogosti neželeni učinki (prizadenejo lahko več kot 1 od 10 bolnikov)
English: Reduction of the dose to 50 mg twice daily is recommended in patients receiving medicines that strongly inhibit CYP3A4, for example some macrolides, azole antifungals, protease inhibitors, or medicines that strongly inhibit CYP2C19, for example omeprazole (see sections 4.4 and 4.5).
Slovenian: Pri bolnikih, ki prejemajo zdravila, ki močno zavirajo encim CYP3A4, na primer nekatere makrolide, azolne antimikotike, zaviralce proteaze ali zdravila, ki močno zavirajo encim CYP2C19, na primer omeprazol (glejte poglavji 4.4 in 4.5), se priporoča zmanjšanje odmerka na 50 mg dvakrat na dan.
English: Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitor excl. heparin.
Slovenian: Farmakoterapevtska skupina: Antitrombotiki, zaviralci agregacije trombocitov brez heparina oznaka ATC: B01AC
English: Cilostazol is a PDE III inhibitor with antiplatelet activity.
Slovenian: Cilostazol je zaviralec PDE III s protitrombocitnim delovanjem.
English: METHOD AND ROUTE(S) OF ADMINISTRATION
Slovenian: POSTOPEK IN POT(I) UPORABE ZDRAVILA za peroralno uporabo
English: There are no data in patients with moderate to severe hepatic impairment and since cilostazol is extensively metabolised by hepatic enzymes, the medicine must not be used in such patients (see section 4.3).
Slovenian: Ker se cilostazol obsežno presnavlja z jetrnimi encimi, ga ti bolniki ne smejo jemati (glejte poglavje 4.3).
English: In this leaflet:
Slovenian: Pogostnosti ustrezajo:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One tablet contains 50 mg of cilostazol.
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena tableta vsebuje 50 mg cilostazola.
English: The dehydro metabolite and 4'-transhydroxy metabolite are 97.4% and 66% protein bound respectively.
Slovenian: Na beljakovine je vezanega 97,4 % presnovka dehidro in 66 % presnovka 4'-trans-hidroksi.
English: The other ingredients are maize starch, microcrystalline cellulose, carmellose calcium, hypromellose and magnesium stearate.
Slovenian: • Druge sestavine zdravila so koruzni škrob, mikrokristalna celuloza, kalcijev karmelozat,
English: SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET
Slovenian: PRILOGA III POVZETEK GLAVNIH ZNAČILNOSTI ZDRAVILA OZNAČEVANJE IN NAVODILO ZA UPORABO
English: In rats dosed during pregnancy, foetal weights were decreased.
Slovenian: Pri brejih podganah je dajanje zdravila povzročilo zmanjšanje telesne mase zarodka.
English: if you have persistent chest pain at rest, or have had a “heart attack” or any heart surgery in the last six months if you have now or previously suffered from blackouts due to heart disease, or any severe disturbances of the heart beat.
Slovenian: • če imate med mirovanjem v prsnem košu stalno bolečino ste imeli "srčni napad" ali poseg na srcu v zadnjih šestih mesecih
English: Caution is advised when cilostazol is co-administered with CYP3A4 substrates with a narrow therapeutic index (e.g., cisapride, halofantrine, pimozide, ergot derivates).
Slovenian: Pri sočasnem dajanju cilostazola s substrati CYP3A4 z ozkim terapevtskim indeksom (npr. cisaprid, halofantrin, pimozid, derivati ergota) je potrebna previdnost.
English: Maize starch, microcrystalline cellulose, carmellose calcium, hypromellose and magnesium stearate.
Slovenian: 6.1 Seznam pomožnih snovi koruzni škorb, mikrokristalna celuloza, kalcijev karmelozat, hipromeloza in magnezijev stearat [Izpolni država članica]
English: Interstitial pneumonia
Slovenian: • pljučnica
English: Musculoskeletal, connective tissue and bone disorders
Slovenian: Bolezni mišično-skeletnega sistema in vezivnega tkiva občasni mialgija
English: One tablet contains 100 mg cilostazol.
Slovenian: Ena tableta vsebuje 100 mg cilostazola.
English: Based on AUC, the overall pharmacological activity of cilostazol increases 35% when co-administered with ketoconazole.
Slovenian: Na podlagi AUC se je skupna farmakološka dejavnost cilostazola povečala za 35 % pri sočasni uporabi s ketokonazolom.
English: One tablet contains 50 mg cilostazol.
Slovenian: Ena tableta vsebuje 50 mg cilostazola.
English: Inhibitors of platelet aggregation
Slovenian: Zaviranje agregacije trombocitov
English: The transfer of cilostazol to breast milk has been reported in animal studies.
Slovenian: Iz študij pri živalih poročajo o prehajanju cilostazola v materino mleko.
English: Cytochrome P-450 (CYP) enzyme inhibitors
Slovenian: Zaviralci encima citokroma P-450 (CYP)
English: Administration of cilostazol with omeprazole (an inhibitor of CYP2C19) increased the AUC of cilostazol by 22%, accompanied by a 68% increase in the AUC of the dehydro metabolite and a decrease of 36% in the AUC of the 4`-trans hydroxy metabolite.
Slovenian: Dajanje cilostazola z omeprazolom (zaviralec CYP2C19) je povečalo AUC cilostazola za 22 %, kar je spremljalo 68-odstotno povečanje AUC presnovka dehidro in 36-odstotno zmanjšanje AUC presnovka 4`-trans hidroksi.
English: No dosage adjustment is necessary in patients with mild hepatic disease.
Slovenian: Pri bolnikih z blago boleznijo jeter ni treba prilagoditi odmerka.
English: Ear and labyrinth disorders Unknown
Slovenian: Ušesne bolezni, vključno z motnjami labirinta neznana tinitus
English: Based on AUC, the overall pharmacological activity increases by 47% when co-administered with omeprazole.
Slovenian: Na podlagi AUC se je skupna farmakološka dejavnost pri sočasnem dajanju z omeprazolom povečala za 47 %.
English: Administration of cilostazol with diltiazem (a weak inhibitor of CYP3A4) resulted in an increase in the AUC of cilostazol of 44%, accompanied by a 4% increase in AUC of the dehydro metabolite and a 43% increase in the AUC of the 4`-trans-hydroxy metabolite.
Slovenian: Dajanje cilostazola z diltiazemom (šibek zaviralec CYP3A4) je povzročilo povečanje AUC cilostazola za 44 %, kar je spremljalo 4-odstotno povečanje AUC presnovka dehidro in 43-odstotno povečanje AUC presnovka 4`-trans-hidroksi.
English: Myocardial infarction, atrial fibrillation, congestive heart failure, supraventricular tachycardia, ventricular tachycardia, syncope
Slovenian: Srčne bolezni pogosti palpitacije, tahikardija, angina pektoris, aritmija, ventrikularne ekstrasistole občasni miokardni infarkt, atrijska fibrilacija, kongestivno srčno popuščanje, supraventrikularna tahikardija, ventrikularna tahikardija, sinkopa
English: A higher rate of haemorrhage was observed with the concomitant use of clopidogrel, ASA and cilostazol in the CASTLE trial.
Slovenian: Pri sočasni uporabi klopidogrela, ASK in cilostazola so v preskušanju CASTLE opazili višjo stopnjo krvavitev.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS {Blister}
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU
English: Cilostazol is only recommended for patients whose symptoms have not improved sufficiently after making life-style modifications (such as stopping smoking and increasing exercise) and after other appropriate interventions.
Slovenian: Cilostazol se priporoča le za bolnike, pri katerih sprememba življenjskega sloga (kot je prenehanje kajenja in več telesne vadbe) in drugi ustrezni ukrepi niso ustrezno izboljšali njihovih simptomov.
English: Cytochrome P-450 enzyme substrates
Slovenian: Substrati encima citokroma P-450
English: Take special care with <Cilostazol-containing medicinal product> Before taking <Cilostazol-containing medicinal product> make sure your doctor knows: if you have a severe heart problem or any problems with your heart beat.
Slovenian: Bodite posebno pozorni pri jemanju <zdravila, ki vsebuje cilostazol> Preden vzamete <zdravilo, ki vsebuje cilostazol>, povejte svojemu zdravniku:
English: Co-administration of ketoconazole (an inhibitor of CYP3A4 with cilostazol resulted in a 117% increase in the AUC of cilostazol, accompanied by a 15% decrease in the AUC of the dehydro metabolite and a 87% increase in the AUC of the 4`-trans-hydroxy metabolite.
Slovenian: Sočasno dajanje ketokonazola (zaviralca CYP3A4) s cilostazolom je povzročilo 117-odstotno povečanje AUC cilostazola, kar je spremljajo 15-odstotno zmanjšanje AUC presnovka dehidro in 87 % povečanje AUC presnovka 4`-trans-hidroksi.
English: Hepatitis, hepatic function abnormal, jaundice
Slovenian: Bolezni jeter, žolčnika in žolčevodov neznana hepatitis, nenormalno delovanje jeter, zlatenica
English: Administration of cilostazol with erythromycin (an inhibitor of CYP3A4) resulted in an increase in the AUC of cilostazol by 72%, accompanied by a 6% increase in AUC of the dehydro metabolite and a 119% increase in AUC of the 4`-trans-hydroxy metabolite.
Slovenian: Uporaba cilostazola z eritromicinom (zaviralec CYP3A4) je povzročila povečanje AUC cilostazola za 72 %, kar je spremljalo 6-odstotno zvišanje AUC presnovka dehidro in 119-odstotno povišanje AUC presnovka 4`-trans-hidroksi.
English: <Cilostazol-containing medicinal product> 50 mg <Cilostazol-containing medicinal product> 100 mg [To be completed nationally]
Slovenian: < Cilostazol-containing medicinal product > 50 mg tablets
English: Based on AUC, overall pharmacological activity of cilostazol increases 19 % when co-administered with diltiazem.
Slovenian: Na podlagi AUC se je skupna farmakološka dejavnost cilostazola povečala za 19 % pri sočasni uporabi z diltiazemom.
English: Based on AUC, the overall pharmacological activity of cilostazol increases 34% when co-administered with erythromycin.
Slovenian: Na podlagi AUC se je skupna farmakološka dejavnost cilostazola povečala za 34 % pri sočasni uporabi z eritromicinom.
English: Cytochrome P-450 enzyme inducers
Slovenian: Induktorji encima citokroma P-450
English: What <Cilostazol-containing medicinal product> contains The active substance is cilostazol.
Slovenian: Kaj vsebuje <zdravilo, ki vsebuje cilostazol>
English: Hot flushes, hypertension, hypotension, cerebral haemorrhage, pulmonary haemorrhage, muscle haemorrhage, respiratory tract haemorrhage, subcutaneous haemorrhage
Slovenian: Žilne bolezni občasni krvavitev očesa, epistaksa, krvavitev prebavil, nedoločena krvavitev, ortostatska hipotenzija neznana vročinski oblivi, hipertenzija, hipotenzija, cerebralna krvavitev, pljučna krvavitev, mišična krvavitev, krvavitev dihal, podkožna krvavitev
English: Tinnitus
Slovenian: • tesnoba
English: Oedema (peripheral, face), anorexia
Slovenian: Presnovne in prehranske motnje pogosti edem (periferni, obrazni), anoreksija občasni hiperglikemija, sladkorna bolezen
English: Medicinal product subject to medicinal prescription [To be completed nationally]
Slovenian: ŠTEVILKA (ŠTEVILKE) DOVOLJENJA ZA PROMET Z ZDRAVILOM [Izpolni država članica]
English: An increased frequency of retardation of ossification of the sternum was observed in rabbits.
Slovenian: Pri kuncih so opazili večjo pogostnost zapoznele okostenitev prsnice.
English: NAME OF THE MEDICINAL PRODUCT Cilostazol-containing medicinal product (see Annex I) 50 mg tablets Cilostazol-containing medicinal product (see Annex I) 100 mg tablets [See Annex I - To be completed nationally]
Slovenian: IME ZDRAVILA <Zdravilo, ki vsebuje cilostazol> (glejte prilogo I), 50 mg tablete <Zdravilo, ki vsebuje cilostazol> (glejte prilogo I), 100 mg tablete [glejte Prilogo I - izpolni država članica] cilostazol
English: Bleeding tendency, thrombocytopenia, granulocytopenia, agranulocytosis, leukopenia, pancytopenia, aplastic anaemia
Slovenian: Bolezni krvi in limfatičnega sistema pogosti ekhimoza občasni anemija redki podaljšan čas krvavitve, trombocitemija neznana nagnjenost h krvavitvam, trombocitopenija, granulocitopenija, agranulocitoza, levkopenija, pancitopenija, aplastična anemija
English: Keep this leaflet.
Slovenian: Pretisni omoti
English: MARKETING AUTHORISATION NUMBER(S)
Slovenian: ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET Z ZDRAVILOM [Izpolni država članica]
English: noticeable bleeding easy bruising serious illness with blistering of the skin, mouth, eyes and genitals yellowing of the skin or whites of the eyes caused by liver or blood problems (jaundice)
Slovenian: • porumenelost kože ali beločnice zaradi težav z jetri ali krvjo (zlatenica)
English: Hepatic impairment
Slovenian: • splošno slabo počutje
English: Insomnia, abnormal dreams
Slovenian: • neobičajne sanje
English: Rare side effects (affecting less than 1 in 1,000, but more than 1 in 10,000 people): tendency to bleed for longer than usual increase in the platelets in the blood problems with the kidneys
Slovenian: Redki neželeni učinki (prizadenejo lahko manj kot 1 od 1.000, a več kot 1 od 10.000 bolnikov)
English: Read all of this leaflet carefully before you start taking this medicine.
Slovenian: Pred začetkom jemanja zdravila natančno preberete navodilo, ker vsebuje za vas pomembne podatke!
English: Hyperglycaemia, Diabetes mellitus
Slovenian: hipromeloza in magnezijev stearat.
English: BEFORE YOU TAKE <CILOSTAZOL-CONTAINING MEDICINAL PRODUCT>
Slovenian: Če ste pozabili vzeti <zdravilo, ki vsebuje cilostazol>
English: Taking other medicines
Slovenian: IME ZDRAVILA
English: White, round, flat faced tablets debossed with “OG31” on one side.
Slovenian: FARMACEVTSKA OBLIKA tableta bele, okrogle, ploske tablete z natisom "OG31" na eni strani.
English: Haematuria, pollakiuria
Slovenian: • vnetje žrela
English: The excretion of cilostazol in human milk is unknown.
Slovenian: Ni znano, ali se cilostazol izloča v materino mleko.
English: This medicinal product is authorised in the Member States of the EEA under the following names: [See Annex I - To be completed nationally]
Slovenian: Zdravilo je v državah članicah EGP pridobilo dovoljenje za promet z naslednjimi imeni: Francija
English: HOW TO STORE <CILOSTAZOL-CONTAINING MEDICINAL PRODUCT> Keep <Cilostazol-containing medicinal product> out of the reach and sight of children.
Slovenian: Shranjevanje <zdravila, ki vsebuje cilostazol> <Zdravilo, ki vsebuje cilostazol>, shranjujte nedosegljivo otrokom!
English: for five days did not result in prolongation of bleeding time.
Slovenian: V kliničnih študijah so zdravim osebam 5 dni dajali 150 mg cilostazola dvakrat na dan, kar ni povzročilo podaljšanja časa krvavitve.
English: Caution is advised when coadministering cilostazol with any drug that inhibits platelet aggregation.
Slovenian: Pri sočasni uporabi cilostazola s katerim koli drugim zdravilom, ki zavira agregacijo trombocitov, je potrebna previdnost.
English: Known hypersensitivity to cilostazol or to any of the excipients Severe renal impairment: creatinine clearance of  25 ml/min Moderate or severe hepatic impairment
Slovenian: • huda ledvična okvara: očistek kreatinina  25 ml/min
English: An increase in the frequency of palpitation and peripheral oedema was observed when cilostazol was combined with other vasodilators that cause reflex tachycardia e.g. dihydropyridine calcium channel blockers.
Slovenian: Pri kombinirani uporabi cilostazola z drugimi vazodilatatorji, ki povzročajo refleksno tahikardijo, npr. z dihidropiridinskimi kalcijevimi antagonisti, so opazili večjo pogostnost palpitacij in perifernih edemov.
English: if you know that you have a condition which increases your risk of bleeding or bruising, such as: - active stomach ulcer(s).
Slovenian: • če veste, da imate bolezen, zaradi katere ste bolj izpostavljeni tveganju krvavitev ali modric, kot so: - aktivna(e) razjeda(e) želodca, - možganska kap v zadnjih šestih mesecih, - težave z očmi, ker imate sladkorno bolezen, - neustrezno nadziran krvni tlak,
English: Skin and subcutaneous tissue disorders
Slovenian: • ekcem in drugi kožni izpuščaji
English: Cilostazol should be taken 30 minutes before breakfast and the evening meal.
Slovenian: Priporočeni odmerek cilostazola je 100 mg dvakrat na dan. Cilostazol se jemlje 30 minut pred zajtrkom ali večerjo.
English: Gastritis
Slovenian: OVOJNINA
English: For breast-feeding mothers use of <Cilostazol-containing medicinal product> is NOT RECOMMENDED.
Slovenian: Jemanje <zdravila, ki vsebuje cilostazol>, se med dojenjem NE PRIPOROČA.
English: Immune system disorders Uncommon
Slovenian: Očesne bolezni neznana konjunktivitis
English: If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Slovenian: Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom ali farmacevtom.
English: STATEMENT OF ACTIVE SUBSTANCE(S) One tablet contains 50 mg of cilostazol.
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena tableta vsebuje 50 mg cilostazola.
English: NAME OF THE MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally]
Slovenian: IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM [izpolni država članica] [glejte Prilogo I - izpolni država članica]
English: NAME OF THE MEDICINAL PRODUCT Cilostazol-containing medicinal products (see Annex I) 50 mg tablets Cilostazol-containing medicinal products (see Annex I) 100 mg tablets [See Annex I - To be completed nationally] Cilostazol
Slovenian: Zdravilo, ki vsebuje cilostazol (glejte prilogo I), 50 mg tablete Zdravilo, ki vsebuje cilostazol (glejte prilogo I), 100 mg tablete Cilostazol
English: MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally]
Slovenian: IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM [Izpolni država članica] <[glejte Prilogo I - Izpolni država članica]>